If you notice text formatting issues, please update your browser to view the website correctly
.
See More
If you notice text formatting issues, please update your browser to view the website correctly
.
See MoreIf you notice text formatting issues, please update your browser to view the website correctly
.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
Flow cytometric analysis of HLA-DQ expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histograms) or Alexa Fluor® 647 Mouse Anti-Human HLA-DR antibody (Cat. No . 564806; solid line histograms). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms showing HLA-DQ expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of either intact lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of HLA-DQ expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histograms) or Alexa Fluor® 647 Mouse Anti-Human HLA-DR antibody (Cat. No . 564806; solid line histograms). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms showing HLA-DQ expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of either intact lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of HLA-DQ expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histograms) or Alexa Fluor® 647 Mouse Anti-Human HLA-DR antibody (Cat. No . 564806; solid line histograms). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms showing HLA-DQ expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of either intact lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of HLA-DQ expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histograms) or Alexa Fluor® 647 Mouse Anti-Human HLA-DR antibody (Cat. No . 564806; solid line histograms). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms showing HLA-DQ expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of either intact lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of HLA-DQ expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histograms) or Alexa Fluor® 647 Mouse Anti-Human HLA-DR antibody (Cat. No . 564806; solid line histograms). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms showing HLA-DQ expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of either intact lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of HLA-DQ expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histograms) or Alexa Fluor® 647 Mouse Anti-Human HLA-DR antibody (Cat. No . 564806; solid line histograms). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms showing HLA-DQ expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of either intact lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of HLA-DQ expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histograms) or Alexa Fluor® 647 Mouse Anti-Human HLA-DR antibody (Cat. No . 564806; solid line histograms). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms showing HLA-DQ expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of either intact lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of HLA-DQ expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histograms) or Alexa Fluor® 647 Mouse Anti-Human HLA-DR antibody (Cat. No . 564806; solid line histograms). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms showing HLA-DQ expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of either intact lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of HLA-DQ expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histograms) or Alexa Fluor® 647 Mouse Anti-Human HLA-DR antibody (Cat. No . 564806; solid line histograms). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms showing HLA-DQ expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of either intact lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of HLA-DQ expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histograms) or Alexa Fluor® 647 Mouse Anti-Human HLA-DR antibody (Cat. No . 564806; solid line histograms). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms showing HLA-DQ expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of either intact lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of HLA-DQ expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histograms) or Alexa Fluor® 647 Mouse Anti-Human HLA-DR antibody (Cat. No . 564806; solid line histograms). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms showing HLA-DQ expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of either intact lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of HLA-DQ expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 557715; dashed line histograms) or Alexa Fluor® 647 Mouse Anti-Human HLA-DR antibody (Cat. No . 564806; solid line histograms). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms showing HLA-DQ expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of either intact lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The TU169 monoclonal antibody specifically binds to the human Major Histocompatibility Complex (MHC) Class II HLA-DQ1 and DQ2 antigens and weakly to HLA-DQ3. HLA-DQ antigens exits as heterodimers comprised of polymorphic transmembrane HLA-DQ alpha and beta glycoproteins. HLA-DQ is expressed primarily on B cells, monocytes, macrophages, dendritic cells and activated T lymphocytes. HLA-DQ is involved in presenting peptidic antigens to CD4+ T lymphocytes. This antibody does not cross-react with HLA-DR2 and HLA-DR7. This antibody fixes complement.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.